Anabela. Silva-Fernandes, et.al., Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease., Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014, 11

http://rdf.ncbi.nlm.nih.gov/pubmed/24477711

Anabela. Silva-Fernandes, et.al., Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease., Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014, 11

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(CMV-ATXN3*135Q)CPama
  http://metadb.riken.jp/db/mgi_rdf/MGI:5646300

class

http://purl.org/net/cito/citesAsAuthority

• Tg(CMV-ATXN3*135Q)CPama
  http://metadb.riken.jp/db/mgi_rdf/MGI:5646300

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• tremors_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0000745C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• decreased brain size_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0000774C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• abnormal substantia nigra morphology_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0000836C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• abnormal pons morphology_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0000848C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• decreased body weight_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001262C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• hypoactivity_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001402C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
他15件を見る
• impaired coordination_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001405C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• abnormal gait_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001406C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• short stride length_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001407C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• decreased exploration in new environment_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001417C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• abnormal posture_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001504C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• limb grasping_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001513C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• impaired swimming_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001522C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• impaired balance_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0001525C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• abnormal motor capabilities/coordination/movement_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0002066C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• decreased brain weight_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0002175C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• neurodegeneration_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0002229C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• astrocytosis_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0003354C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• abnormal muscle tone_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0004142C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• neuronal intranuclear inclusions_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0004191C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama
• decreased grip strength_Tg(CMV-ATXN3*135Q)CPama/0
  http://metadb.riken.jp/0010053C57BL6TgCMVATXN3135QCPamaTgCMVATXN3135QCPama0TgCMVATXN3135QCPama